Use of glutathione synthesis stimulating compounds in reducing insulin resistance
US7622447B2 · kind B2 · utility
17Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2003 |
| Grant date | Nov 24, 2009 |
| Priority date | — |
| Expiry date | Jan 27, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a method of reducing insulin resistance in a mammalian patient comprising selecting a patient suffering from insulin resistance and administering a compound which increases hepatic glutathione and a compound which increases hepatic nitric oxide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.